Pharmacological inhibition and genetic knock-down of LRP-1 in APP/PS1 mouse model of AD accelerated brain accumulation of Aβ and exacerbated Aβ deposition as amyloid plaques and cerebral amyloid angiopathy without affecting Aβ production (Kanekiyo et al., 2012). This evidence concerns the gene LRP1 and Alzheimer disease.